logo
AAT Bioquest

CDK9/cyclin T1 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
SeliciclibIC50800.0 [1]
SeliciclibKi790.0 [1]
AlvocidibIC504.59 [1]
AlvocidibKi3.0 [1]
DinaciclibIC504.0 [1], 178.0 [2]
4-[(E)-(3,5-Diamino-1h-Pyrazol-4-Yl)diazenyl]phenolIC50150.0 [1], 350.0 [2]
4-[(E)-(3,5-Diamino-1h-Pyrazol-4-Yl)diazenyl]phenolKi350.0 [1]
StaurosporineIC503.3 [1], 14.0 [2]
StaurosporineKi7.0 [1]
AbemaciclibIC5057.0 [1], 101.0 [2]
AbemaciclibKi57.0 [1]
Sns-032IC504.0 [1], 40.0 [2]
4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamideIC5010.0 [1]
4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamideKi100.0 [1]
(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamideIC5044.0 [1], 230.0 [2]
4-(4-Methoxy-1h-Pyrrolo[2,3-B]pyridin-3-Yl)pyrimidin-2-AmineIC506.0 [1]
4-(1H-Pyrrolo[2,3-B]pyridin-3-YL)pyrimidin-2-amineIC5026.0 [1], 30.0 [2]
RibociclibIC50197.0 [1]
RohitukineIC50300.0 [1]
CID 23643976IC5020.0 [1]
Leucettine L41IC5010000.0 [1], 18000.0 [2]
(2R)-2-{[4-(Benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-olIC5043.0 [1]
3-[[5-Cyano-4-[4-Methyl-2-(Methylamino)-1,3-Thiazol-5-Yl]pyrimidin-2-Yl]amino]benzenesulfonamideKi6.0 [1]
[4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amineKi4.0 [1]
[3-[[6-(2-Benzyloxyphenyl)pyrimidin-4-yl]amino]phenyl]methyl-propyl-phosphinic acidIC50142.0 [1]
4-(4-Propoxy-1h-Pyrrolo[2,3-B]pyridin-3-Yl)pyrimidin-2-AmineIC505.6 [1], 6.0 [2]
Meriolin 9IC5010000.0 [1]
Meriolin 2IC5018.0 [1]
4-[4-Methyl-2-(methylamino)-1,3-thiazol-5-yl]-2-[3-(morpholine-4-carbonyl)anilino]pyrimidine-5-carbonitrileKi43.0 [1]
4-(4-Methyl-2-(methylamino)thiazol-5-yl)-2-(3-nitrophenylamino)pyrimidine-5-carbonitrileKi6.0 [1]
2-[3-(1,4-Diazepan-1-yl)anilino]-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidine-5-carbonitrileKi7.0 [1]
N-Methyl-5-[2-(3-nitroanilino)pyrimidin-4-yl]-4-phenyl-1,3-thiazol-2-amineKi5000.0 [1], 9835.0 [2]
1-[4-[4-[[5-(Oxan-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]cyclohexyl]piperazin-1-yl]ethanoneIC501890.0 [1], 30000.0 [2]
3-Benzyl-1-[4-[(5-cyanopyridin-2-yl)amino]cyclohexyl]-1-[4-(1-methylpyrazol-4-yl)phenyl]ureaIC5030000.0 [1]
1-[4-[4-[(5-Propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl)amino]cyclohexyl]piperazin-1-yl]ethanoneIC50890.0 [1], 30000.0 [2]
HarmineIC50720.0 [1]
5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazoleKi340.0 [1]
PalbociclibKi364.0 [1]
DoramapimodIC5030000.0 [1]
Indirubin-3'-monoximeIC502400.0 [1]
KenpaulloneIC5064.0 [1]
FascaplysinIC50250000.0 [1]
N3-(4-Fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidine-3,4-diamineKi10000.0 [1]
Pik-75IC501.37 [1]
O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purineIC501070.0 [1]
PaulloneIC50810.0 [1]
CercosporamideIC50220.0 [1]
Olomoucine IIIC50815.0 [1]
4-Methyl-5-(2-((4-morpholinophenyl)amino)-pyrimidin-4-yl)thiazol-2-amineKi480.0 [1]
Pha-793887IC50138.0 [1]
BS-181IC501790.0 [1]
3-(2-Aminopyrimidin-4-yl)-1H-indol-4-olIC502400.0 [1]
RGB-286638 free baseIC501.0 [1]
VoruciclibIC5022.0 [1]
(2S,3S)-3-((7-(Benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)butane-1,2,4-triolIC5090.0 [1]
Leucettamine BIC5010000.0 [1]
CID 71561915Ki4.0 [1]
CID 78357764IC5011.0 [1]
3,5-Diamino-4-phenylazopyrazoleIC5015000.0 [1]
N-[2-(1H-Indol-3-yl)ethyl]-N-methyl-4-phenylbenzamideIC501000000.0 [1]
5-(2-Aminopyrimidin-4-yl)-2-phenyl-1H-pyrrole-3-carboxamideIC50394.0 [1]
Cyc065IC5026.0 [1]
Cyclapolin 9IC50100000.0 [1]
4-[4-Methyl-2-(methylamino)-1,3-thiazol-5-yl]-2-(4-methyl-3-morpholin-4-ylsulfonylanilino)pyrimidine-5-carbonitrileKi22.0 [1]
Ethyl 4-[(4-fluorophenyl)amino]-5-methylthieno[2,3-d]pyrimidine-6-carboxylateKi10000.0 [1]
(2~{R},3~{S})-3-[[9-Propan-2-yl-6-(pyridin-3-ylmethylamino)purin-2-yl]amino]pentan-2-olIC50110.0 [1]
(2-Methyl-4,5-dihydro-thiazolo[4,5-h]quinazolin-8-yl)-(3-nitro-phenyl)-amineKi2.0 [1]
2(3H)-Thiazolone, 3,4-diMethyl-5-[2-[[4-(1-piperazinyl)phenyl]aMino]-4-pyriMidinyl]-Ki0.4 [1]
N-(2-(1H-Indol-3-yl)ethyl)-4-chloro-N-methylbenzamideIC501000000.0 [1]
N-(2-(1H-Indol-3-yl)ethyl)-4-tert-butyl-N-methylbenzamideIC501000000.0 [1]
N-[5-[[6-(3-Aminophenyl)pyrimidin-4-yl]amino]-2-methyl-phenyl]methanesulfonamideIC50129.0 [1]
CDK12 inhibitor 2IC5016000.0 [1]
2-N-(4-Aminocyclohexyl)-8-propan-2-yl-4-N-[(4-pyridin-2-ylphenyl)methyl]pyrazolo[1,5-a][1,3,5]triazine-2,4-diamineIC5049.0 [1]
4-[[[4-[5-Chloro-2-[[4-(2-methoxyethylamino)cyclohexyl]amino]pyridin-4-yl]-1,3-thiazol-2-yl]amino]methyl]oxane-4-carbonitrileIC501.0 [1]
(4Z)-2-[4-[2-[2-[2-(2-Aminoethoxy)ethoxy]ethoxy]ethoxy]anilino]-4-(1,3-benzodioxol-5-ylmethylidene)-1H-imidazol-5-oneIC503700.0 [1]
2-(2-Fluorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-oneIC502.8 [1]
5,7-Dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-2-phenylchromen-4-oneIC509.0 [1]
2-(4-Fluorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-oneIC502.1 [1]
2-(4-Bromophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-oneIC505.5 [1]
5,7-Dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-2-[4-(trifluoromethyl)phenyl]chromen-4-oneIC5019.0 [1]
5,7-Dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-2-(4-hydroxyphenyl)chromen-4-oneIC509.6 [1]
5,7-Dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-2-pyridin-4-ylchromen-4-oneIC506.5 [1]
2-(4-Ethenylphenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-oneIC509.5 [1]
(2r)-2-{[7-(Benzylamino)-3-(Propan-2-Yl)-1h-Pyrazolo[4,3-D]pyrimidin-5-Yl]amino}butan-1-OlIC501000.0 [1]
(Arylindolyl)maleimide deriv. 27IC5080.0 [1]
1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)ureaIC5030000.0 [1]
3-[[6-(2-Methoxyphenyl)pyrimidin-4-yl]amino]benzenesulfonamideIC5052.0 [1]
2-Anilino-4-(thiazol-5-yl)pyrimidine deriv. 30Ki2.0 [1]
6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-oneIC5010000.0 [1]
N-[5-[[6-(2-Methoxyphenyl)pyrimidin-4-yl]amino]-2-methylphenyl]methanesulfonamideIC5030.0 [1]
2-Anilino-7-[(1S)-4-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethylpyrrolo[2,3-d]pyrimidin-6-oneIC501582.0 [1]
2-[3-(4-Acetyl-1,4-diazepan-1-yl)anilino]-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidine-5-carbonitrileKi7.0 [1]
CID 76072859IC50749.0 [1]
CID 86579886IC50360.0 [1]
6-(2-Methoxyphenyl)-N-[4-[propan-2-yloxy(propyl)phosphoryl]oxyphenyl]pyrimidin-4-amineIC50407.0 [1]
CID 86579888IC502840.0 [1]
CID 86579889IC5010000.0 [1]
6-(3-Nitrophenyl)-N-[4-[propan-2-yloxy(propyl)phosphoryl]oxyphenyl]pyrimidin-4-amineIC5010000.0 [1]
CID 86579891IC503840.0 [1]
6-(3-Aminophenyl)-N-[4-[propan-2-yloxy(propyl)phosphoryl]oxyphenyl]pyrimidin-4-amineIC506060.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ CDK9/cyclin T1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Nov2024https://www.aatbio.com/data-sets/cdk9-cyclin-t1-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 21). Quest Database™ CDK9/cyclin T1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/cdk9-cyclin-t1-inhibitors-ic50-ki.
BibTeXEndNoteRefMan